Home › Clinical Trials › Find A Research Study

Find A Research Study

Study Title: Liver Cancer (Hepatocellular Carcinoma): Sorafenib vs Placebo as Adjuvant Treatment
Category: Cancer, General

Currently accepting participants?
Yes - please read the description below and contact the study coordinator if you are interested.

Principal Investigator: Thomas Malpass
Study Coordinator: Andrea Jacks
Phone: 206-625-7373 Ext.63979
Email: andrea.jacks@vmmc.org

What is the Liver Cancer (Hepatocellular Carcinoma): Sorafenib vs Placebo as Adjuvant Treatment study?

Please visit clinicaltrials.gov and enter the ID NCT00692770

Who can participate?

Patients diagnosed for the first time with hepatocellular carcinoma. Patients who have recently had surgical resection or ablation with curative intent. Patients who have a low-risk of recurrence are not eligible to participate. Patients who are already taking anti-cancer therapy are not eligible.

Study Summary:

The study will include subjects diagnosed for the first time with HCC. After surgery or ablation, subjects will be randomized to sorafenib or placebo.

Detailed Study Description:

Please visit clinicaltrials.gov and enter the ID NCT00692770

Study Design: Interventional, Blinded
Phase of Study: Phase III
Study Type: Interventional
Condition or Study Focus: Hepatocellular Carcinoma (Liver Cancer)
Intervention Type: Drug
Intervention Name: Sorafenib Tablets
Gender: Male and Female
Age group: Interventional
Sponsor: Bayer


Other studies in this category include:

Studies currently accepting study participants:

Studies currently not accepting study participants: